111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Other expenses growth above 1.5x CX's 25.14%. Michael Burry would check for concerning trends.
100.00%
Operating expenses growth above 1.5x CX's 10.46%. Michael Burry would check for inefficiency.
100.00%
Total costs growth above 1.5x CX's 8.88%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
139.12%
EBITDA growth exceeding 1.5x CX's 75.20%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
139.12%
Operating income growth exceeding 1.5x CX's 70.77%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Other expenses reduction while CX shows 110.55% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
13.15%
EPS growth while CX declines. John Neff would investigate advantages.
42.60%
Diluted EPS growth while CX declines. John Neff would investigate advantages.
-4.69%
Share count reduction while CX shows 0.00% change. Joel Greenblatt would examine strategy.
-4.69%
Diluted share reduction while CX shows 0.00% change. Joel Greenblatt would examine strategy.